|
|
| | Pemafibrate Basic information |
| Product Name: | Pemafibrate | | Synonyms: | Pemafibrate;K877;(R)-K 13675;PEMAFIBRATE;K-877;(R)-K 13675;CS-2768;Butanoic acid, 2-[3-[[2-benzoxazolyl[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]-, (2R)-;Pemafibrate [(R)-K-13675;(2R)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid | | CAS: | 848259-27-8 | | MF: | C28H30N2O6 | | MW: | 490.55 | | EINECS: | | | Product Categories: | | | Mol File: | 848259-27-8.mol |  |
| | Pemafibrate Chemical Properties |
| Melting point | 98-99 °C(Solv: ethyl acetate (141-78-6); heptane (142-82-5)) | | Boiling point | 676.7±65.0 °C(Predicted) | | density | 1.250±0.06 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Solid | | pka | 3.23±0.10(Predicted) | | color | White to Off-White |
| | Pemafibrate Usage And Synthesis |
| Uses | Pemafibrate is used in the treatment of hyperlipidemia. It also functions as a promising selective PPAR-α modulator for treatment of combined dyslipidemia phase 2 clinical trials with K-877. |
| | Pemafibrate Preparation Products And Raw materials |
|